Owens & Minor Inc/va/ Form 4 insider transactions
Insider transactions: buys and sells by directors, officers and ten percent owners, filed within two business days of the trade.
Heath H. Galloway of Accendra Health Inc. reported a transaction involving the surrender of 1,822 shares to cover tax withholding obligations upon the vesting of restricted stock.
Accendra Health's EVP & CFO, Jonathan A. Leon, reported a transaction involving the surrender of shares to cover tax withholding obligations upon restricted stock vesting.
Edward A. Pesicka, President & CEO of ACCENDRA HEALTH INC/VA/, reported a transaction involving common stock on May 15, 2026.
Heath H. Galloway, EVP, General Counsel & CorpSecy of Accendra Health Inc., reported a transaction involving the surrender of shares to cover tax withholding obligations.
Accendra Health Inc. reports a transaction where EVP Perry A. Bernocchi surrendered shares to cover tax obligations related to restricted stock vesting.
Teresa L. Kline, a Director at Accendra Health, Inc., acquired 31,191 shares of common stock on May 14, 2026.
Director Stephen W. Klemash of Accendra Health, Inc. acquired 31,191 shares of common stock on May 14, 2026, as part of a restricted stock grant.
Director Kenneth Gardner-Smith acquired 31,191 shares of common stock in Accendra Health, Inc. on May 14, 2026.
Gwendolyn M. Bingham, a Director at Accendra Health Inc., reported a transaction involving phantom stock conversion on May 14, 2026.
Mark A. Beck, a Director at ACCENDRA HEALTH, INC., acquired 31,191 shares of common stock on May 14, 2026, as part of a restricted stock grant.
Accendra Health, Inc. President & CEO Edward A. Pesicka disposed of 58,945 shares of common stock to satisfy tax withholding obligations related to restricted stock vesting.
Accendra Health's EVP & CFO, Jonathan A. Leon, disposed of 11,286 common shares to cover tax withholding obligations related to vested restricted stock.
Accendra Health's EVP and COO, Perry A. Bernocchi, disposed of 20,841 common shares to cover tax withholding obligations related to restricted stock vesting.
Accendra Health EVP Heath Galloway disposes of 9,347 common shares to cover tax withholding on restricted stock vesting.
Andrew G. Long, EVP and CEO of Products & Healthcare Services at Owens & Minor, Inc., transferred 47,908 shares of common stock to a family trust.
Owens & Minor's EVP & CFO, Jonathan A. Leon, disposed of 4,265 shares of common stock to cover tax withholding obligations related to restricted stock vesting.
Coliseum Capital Management and related entities significantly increased their beneficial ownership in Owens & Minor Inc. through recent stock purchases.
Jennifer A. Stone, Executive Vice President and Chief Human Resources Officer of Owens & Minor, Inc., disposed of 5,764 shares of common stock to satisfy tax withholding obligations.
Heath H. Galloway, EVP, General Counsel & CorpSecy of Owens & Minor, sold shares to cover tax obligations related to vesting restricted stock.
Director Carissa Rollins reports acquiring 28,914 shares of Owens & Minor common stock and disposing of shares, resulting in a beneficial ownership of 53,902 shares.
Director Teresa L. Kline reports acquiring and disposing of Owens & Minor (OMI) common stock on May 15, 2025, according to a Form 4 filing with the SEC.
Director Robert J. Henkel reports acquisition of 28,914 shares of Owens & Minor common stock and disposal of 77,412 shares.
Director Kenneth Gardner-Smith reports acquisition of 28,914 shares of Owens & Minor common stock and disposal of 54,922 shares on May 15, 2025.
Director Stephen W. Klemash reports acquiring 28,914 shares and disposing of 59,051 shares of Owens & Minor common stock on May 15, 2025.
Rita Johnson-Mills, a director of Owens & Minor Inc./VA/, reported the acquisition and disposal of common stock on May 15, 2025, according to a Form 4 filing with the SEC.
Director Gwendolyn M. Bingham reports acquisition of phantom stock in Owens & Minor, Inc.
Director Mark A. Beck reports acquisition and disposal of Owens & Minor Inc. common stock on May 15, 2025.
Snehashish Sarkar, Chief Information Officer of Owens & Minor, disposed of 4,336 shares of common stock to cover tax obligations related to vesting restricted stock.
Edward A. Pesicka, President & CEO of Owens & Minor, Inc., disposed of 35,208 shares of common stock on May 15, 2025, to cover tax obligations related to vesting restricted stock.
Michael Wayne Lowry, SVP, Corporate Controller of Owens & Minor, Inc., reports the disposition of 1,533 shares of common stock to cover tax obligations related to vesting restricted stock.